Literature DB >> 28149972

Improving your approach to nasal obstruction.

Margaret A Bayard1, Paul Algra2, L Jared Hyman2, Chadwick Donaldson2.   

Abstract

The causes are diverse--from rhinitis and rhinosinusitis to drugs and structural/mechanical abnormalities. Here's how to provide patients with relief.

Entities:  

Mesh：

Year:  2016        PMID： 28149972

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  2 in total

1.  Triamcinolone Acetonide versus Fluticasone Propionate in the Treatment of Perennial Allergic Rhinitis: A Randomized, Parallel-Group Trial.

Authors:  Alexander V Karaulov; Tamara Vylegzhanina; Andrey Ovchinnikov; Mariia Chernikova; Nataiya Nenasheva
Journal:  Int Arch Allergy Immunol       Date:  2019-03-15       Impact factor: 2.749

2.  Protective barrier properties of Rhinosectan® spray (containing xyloglucan) on an organotypic 3D airway tissue model (MucilAir): results of an in vitro study.

Authors:  Barbara De Servi; Francesco Ranzini; Núria Piqué
Journal:  Allergy Asthma Clin Immunol       Date:  2017-08-10       Impact factor: 3.406
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.